BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3523023)

  • 21. [Effect of cranial irradiation on rate of recurrence in children with acute myeloid leukemia. Initial results of the AML-BFM-87 study. The AML-BFM Study Group].
    Creutzig U; Ritter J; Heyen P; Berthold F; Henze G; Kabisch H; Lampert F; Niethammer D; Riehm H; Schellong G
    Klin Padiatr; 1992; 204(4):236-45. PubMed ID: 1518259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukaemia of childhood--follow up after 9 years. Coall Study Group.
    Janka-Schaub GE; Harms D; Goebel U; Graubner U; Gutjahr P; Haas RJ; Juergens H; Spaar HJ; Winkler K
    Eur J Pediatr; 1996 Aug; 155(8):640-8. PubMed ID: 8839716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.
    Escherich G; Horstmann MA; Zimmermann M; Janka-Schaub GE;
    Leukemia; 2010 Feb; 24(2):298-308. PubMed ID: 20016530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of dose intensity and therapy-induced leukocytopenia in intensive therapy on the prognosis of acute lymphatic leukemia in childhood. Results in 213 patients of the COALL-85 study].
    Gobrecht O; Göbel U; Graubner U; Gutjahr P; Schöck V; Spaar HJ; Janka-Schaub GE
    Klin Padiatr; 1992; 204(4):230-5. PubMed ID: 1518258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in the treatment of juvenile leukemias].
    Gadner H; Krepler P; Kundi M; Mutz I; Pichler E; Schmidmeier W; Tulzer W; Urban C
    Wien Med Wochenschr; 1982 Jul; 132(13-14):313-8. PubMed ID: 6958132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
    Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
    Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
    Castel V; Verdeguer A; Ferris J; Esquembre C
    An Esp Pediatr; 1987 Nov; 27(5):331-4. PubMed ID: 3481522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ; Blatt J; Sather HN; Meadows AT
    Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The COALL-85 cooperative study for risk patients with acute lymphatic leukemia: initial results].
    Janka-Schaub GE; Winkler K; Göbel U; Graubner U; Schwenger M; Haas RJ; Jürgens H; Spaar J
    Klin Padiatr; 1988; 200(3):171-6. PubMed ID: 3062253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
    Miller DR; Leikin SL; Albo VC; Sather H; Hammond GD
    J Clin Oncol; 1989 Mar; 7(3):316-25. PubMed ID: 2645385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results and experiences with a modified BFM protocol for treatment of recurrences in children with acute lymphoblastic leukemia in East German areas].
    Sauerbrey A; Zintl F; Malke H; Reimann M; Maaser M; Domula M; Dörffel W; Eggers G; Exadaktylos P; Kotte W
    Klin Padiatr; 1993; 205(4):281-7. PubMed ID: 8377448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
    Sallan SE; Hitchcock-Bryan S; Gelber R; Cassady JR; Frei E; Nathan DG
    Cancer Res; 1983 Nov; 43(11):5601-7. PubMed ID: 6352020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk groups in a multicenter pilot study for treatment of acute lymphoblastic and acute undifferentiated leukemia in adults.
    Hoelzer D; Thiel E; Löffler H; Bodenstein H; Büchner T; Engelhardt R; Ganser A; Messerer D; Rühl H; Zwingers T
    Haematol Blood Transfus; 1985; 29():48-50. PubMed ID: 3861487
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; Rammeloo JA; de Koning J; van Zanen GE
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):61-6. PubMed ID: 3287685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [COALL-80 therapy in the management of acute lymphoblastic leukemia in childhood--an interim report].
    Winkler K; Beron G; Erttmann R; Jürgens H; Göbel U; Gutjahr P; Kabisch H; Kuhn N; Spaar HJ; Drescher J; Thomas P; Landbeck G
    Klin Padiatr; 1983; 195(3):161-7. PubMed ID: 6576203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of acute lymphoblastic leukemia in childhood. Multicenter prospective therapy study COALL-80].
    Winkler K; Beron G; Thöne I; Jürgens H; Goebel U; Gutjahr P; Spaar HJ; Drescher J; Thomas P; Müller-Wickup J; Landbeck G
    Onkologie; 1983 Feb; 6(1):26-32. PubMed ID: 6341910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of childhood acute lymphoblastic leukemia with protocol TCL821: a report of Taiwan Children's Cancer Study Group.
    Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):48-56. PubMed ID: 2666568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
    Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R
    Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.